MA35400B1 - Composition pharmaceutique contenant de la fexofénadine - Google Patents

Composition pharmaceutique contenant de la fexofénadine

Info

Publication number
MA35400B1
MA35400B1 MA36589A MA36589A MA35400B1 MA 35400 B1 MA35400 B1 MA 35400B1 MA 36589 A MA36589 A MA 36589A MA 36589 A MA36589 A MA 36589A MA 35400 B1 MA35400 B1 MA 35400B1
Authority
MA
Morocco
Prior art keywords
pharmaceutical composition
composition containing
containing fexofenadine
composition
preparing
Prior art date
Application number
MA36589A
Other languages
English (en)
Inventor
Sudhakara Rao Badabhagni
Nilesh Jaiswal
Praveen Khullar
Kum Prasad
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of MA35400B1 publication Critical patent/MA35400B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)

Abstract

La présente invention porte sur une composition pharmaceutique de l'hydrochlorure de fexofénadine dans un système de solvant utilisable en tant que composition de remplissage liquide. Un autre aspect de l'invention concerne également un procédé permettant de préparer la composition pharmaceutique susmentionnée et l'utilisation de cette composition pour préparer un médicament destiné au traitement de réactions allergiques chez un patient.
MA36589A 2011-05-20 2013-12-18 Composition pharmaceutique contenant de la fexofénadine MA35400B1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1727CH2011 2011-05-20
US201161499856P 2011-06-22 2011-06-22
EP11305923 2011-07-13
PCT/EP2012/059147 WO2012159960A1 (fr) 2011-05-20 2012-05-16 Composition pharmaceutique contenant de la fexofénadine

Publications (1)

Publication Number Publication Date
MA35400B1 true MA35400B1 (fr) 2014-09-01

Family

ID=47216626

Family Applications (1)

Application Number Title Priority Date Filing Date
MA36589A MA35400B1 (fr) 2011-05-20 2013-12-18 Composition pharmaceutique contenant de la fexofénadine

Country Status (18)

Country Link
US (1) US20140073670A1 (fr)
EP (1) EP2709600A1 (fr)
JP (1) JP2014513708A (fr)
KR (1) KR20140037876A (fr)
CN (1) CN103687592A (fr)
AR (1) AR086491A1 (fr)
BR (1) BR112013029778A2 (fr)
CA (1) CA2835912A1 (fr)
CO (1) CO6831986A2 (fr)
CR (1) CR20130591A (fr)
EA (1) EA201391742A1 (fr)
EC (1) ECSP13013095A (fr)
IL (1) IL229417A0 (fr)
MA (1) MA35400B1 (fr)
MX (1) MX2013013575A (fr)
SG (1) SG195015A1 (fr)
UY (1) UY34080A (fr)
WO (1) WO2012159960A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015003109A1 (fr) * 2013-07-03 2015-01-08 R.P. Scherer Technologies, Llc Formulation de capsules comprenant de la fexofénadine
US9504656B2 (en) * 2013-10-21 2016-11-29 Banner Life Sciences, LLC Pharmaceutical compositions for poorly soluble active ingredients
CN104133014B (zh) * 2014-07-16 2015-09-16 广州法尔麦兰药物技术有限公司 一种考察布洛伪麻缓释制剂释放度的方法
CN107847496A (zh) * 2015-02-20 2018-03-27 英仕柏集团有限责任公司 含有非索非那丁的软明胶胶囊

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929605A (en) 1987-10-07 1990-05-29 Merrell Dow Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol derivatives
US6316473B1 (en) * 1997-04-11 2001-11-13 Fujisawa Pharmaceutical Co., Ltd. Two surfactant-containing medicinal composition
ID24463A (id) 1997-08-14 2000-07-20 Hoechst Marion Roussel Inc Metode meningkatkan ketersediaan hayati feksofenadin dan turunan-turunannya
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
AU2001244610A1 (en) * 2000-04-05 2001-10-23 Shionogi And Co., Ltd. Oil-in-water microemulsions containing tricyclic compounds or preconcentrates thereof
OA12619A (en) * 2001-06-21 2006-06-12 Pfizer Prod Inc Self-emulsifying formulations of cholesteryl estertransfer protein inhibitors.
EP1455753A1 (fr) * 2001-12-20 2004-09-15 Bernard Charles Sherman Compositions pharmaceutiques comprenant une cyclosporine, un tensioactif hydrophile et un tensioactif lipophile
GB2391473B (en) * 2002-08-02 2004-07-07 Satishchandra Punambhai Patel Pharmaceutical compositions
CA2524773C (fr) * 2003-05-08 2014-04-08 Nektar Therapeutics Uk Ltd Coformulations particulaires de substances actives comprenant des excipients
JP2005075804A (ja) * 2003-09-03 2005-03-24 Toyo Capsule Kk メナテトレノン含有医薬組成物
WO2005062722A2 (fr) * 2003-11-21 2005-07-14 Sun Pharmaceutical Industries Limited Composition pharmaceutique orale

Also Published As

Publication number Publication date
CO6831986A2 (es) 2014-01-10
JP2014513708A (ja) 2014-06-05
AR086491A1 (es) 2013-12-18
BR112013029778A2 (pt) 2017-01-17
WO2012159960A1 (fr) 2012-11-29
MX2013013575A (es) 2014-09-15
CN103687592A (zh) 2014-03-26
KR20140037876A (ko) 2014-03-27
US20140073670A1 (en) 2014-03-13
EA201391742A1 (ru) 2014-04-30
CR20130591A (es) 2014-05-07
CA2835912A1 (fr) 2012-11-29
SG195015A1 (en) 2013-12-30
UY34080A (es) 2013-01-03
IL229417A0 (en) 2014-01-30
EP2709600A1 (fr) 2014-03-26
ECSP13013095A (es) 2014-01-31

Similar Documents

Publication Publication Date Title
BR112018003316A2 (pt) compostos e métodos para entrega transmembrana de moléculas
FR2994851B1 (fr) Dispositif d'injection de liquide pharmaceutique configure pour etre pre-rempli
MA35400B1 (fr) Composition pharmaceutique contenant de la fexofénadine
MX2015003653A (es) Derivados de amida del acido benzoimidazol-carboxilico como moduladores del receptor apj.
BR112015006029A2 (pt) compostos aza bicíclicos como agonistas de receptor m1 muscarínicos
MA33442B1 (fr) Préparations d'insuline contenant de la méthionine
EA201591166A1 (ru) Ингибиторы аутотаксина
MA29851B1 (fr) Composes et compositions contenant de la diarylamine et utilisation en tant que modulateurs de recepteurs de c-kit
FR2960542B1 (fr) Peptide en tant que medicament, en particulier pour le traitement du cancer
MA38260A1 (fr) Nouveaux dérivés de cyclohexyl et quinuclidinyl carbamate ayant une activité d'agoniste adrénergique beta2 et une activité d'antagoniste muscarinique m3
MA35450B1 (fr) Molécules de liaison pour bcma et cd3
EA201491161A1 (ru) Фторированные модуляторы рецепторов эстрогенов и их применение
BR112015000150A2 (pt) composições farmacêuticas dissuasoras de abuso de liberação controlada
MA37888A1 (fr) Composition pharmaceutique enrobée contenant du régorafenib
TR201903492T4 (tr) Apomorfin ve organik asitler içeren bileşimler ve bunların kullanım alanları.
BR112014012056A8 (pt) compostos farmacêuticos
MA35455B1 (fr) (wo2013045407) dérivés d'estra-1,3,5(10),16-tétraène-3-carboxamide, procédé pour leur fabrication, préparations pharmaceutiques contenant ces substances ainsi que leur utilisation dans la fabrication de médicaments
MA34545B1 (fr) Co-cristaux et sels d'inhibiteurs de ccr3
MA37777B1 (fr) Préparation pharmaceutique
MA35268B1 (fr) 1-pipérazino-3-phénylindanes deutérés pour le traitement de la schizophrénie
EA201400973A1 (ru) Фармацевтическая композиция для профилактики и лечения психических, поведенческих, когнитивных расстройств
BR112013017933A2 (pt) composição líquida e método para sua fabricação
FR2927539B1 (fr) Procede de preparation d'une formulation pharmaceutique d'agents de contraste.
EA201001000A1 (ru) Антиоксидантное средство масляный бальзам "ювелакс"
MA39406A1 (fr) Promédicament de la 1,1'-(1,6-dioxo-1,6-hexanediyl)bis-d-proline